|
Gene: EML3 |
Gene summary for EML3 |
Gene summary. |
Gene information | Species | Human | Gene symbol | EML3 | Gene ID | 256364 |
Gene name | EMAP like 3 | |
Gene Alias | ELP95 | |
Cytomap | 11q12.3 | |
Gene Type | protein-coding | GO ID | GO:0000070 | UniProtAcc | Q32P44 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
256364 | EML3 | P57T-E | Human | Esophagus | ESCC | 1.64e-15 | 3.10e-01 | 0.0926 |
256364 | EML3 | P61T-E | Human | Esophagus | ESCC | 4.57e-05 | 8.45e-02 | 0.099 |
256364 | EML3 | P62T-E | Human | Esophagus | ESCC | 5.22e-14 | 2.48e-01 | 0.1302 |
256364 | EML3 | P65T-E | Human | Esophagus | ESCC | 1.68e-13 | 1.86e-01 | 0.0978 |
256364 | EML3 | P74T-E | Human | Esophagus | ESCC | 2.35e-15 | 4.40e-01 | 0.1479 |
256364 | EML3 | P75T-E | Human | Esophagus | ESCC | 1.02e-19 | 4.27e-01 | 0.1125 |
256364 | EML3 | P76T-E | Human | Esophagus | ESCC | 2.01e-12 | 1.70e-01 | 0.1207 |
256364 | EML3 | P79T-E | Human | Esophagus | ESCC | 6.13e-07 | 8.77e-02 | 0.1154 |
256364 | EML3 | P80T-E | Human | Esophagus | ESCC | 1.18e-09 | 1.91e-01 | 0.155 |
256364 | EML3 | P82T-E | Human | Esophagus | ESCC | 2.09e-06 | 3.61e-01 | 0.1072 |
256364 | EML3 | P83T-E | Human | Esophagus | ESCC | 3.02e-13 | 4.30e-01 | 0.1738 |
256364 | EML3 | P89T-E | Human | Esophagus | ESCC | 1.84e-04 | 3.32e-01 | 0.1752 |
256364 | EML3 | P91T-E | Human | Esophagus | ESCC | 1.83e-06 | 4.18e-01 | 0.1828 |
256364 | EML3 | P107T-E | Human | Esophagus | ESCC | 5.06e-14 | 3.20e-01 | 0.171 |
256364 | EML3 | P127T-E | Human | Esophagus | ESCC | 3.00e-04 | 6.97e-02 | 0.0826 |
256364 | EML3 | P128T-E | Human | Esophagus | ESCC | 4.45e-38 | 1.23e+00 | 0.1241 |
256364 | EML3 | P130T-E | Human | Esophagus | ESCC | 2.35e-19 | 3.32e-01 | 0.1676 |
256364 | EML3 | C04 | Human | Oral cavity | OSCC | 1.43e-11 | 4.67e-01 | 0.2633 |
256364 | EML3 | C21 | Human | Oral cavity | OSCC | 5.57e-35 | 7.67e-01 | 0.2678 |
256364 | EML3 | C30 | Human | Oral cavity | OSCC | 2.68e-23 | 8.97e-01 | 0.3055 |
Page: 1 2 3 4 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:014001414 | Esophagus | ESCC | mitotic nuclear division | 218/8552 | 287/18723 | 6.17e-26 | 1.78e-23 | 218 |
GO:005165617 | Esophagus | ESCC | establishment of organelle localization | 273/8552 | 390/18723 | 9.13e-23 | 1.81e-20 | 273 |
GO:000007011 | Esophagus | ESCC | mitotic sister chromatid segregation | 138/8552 | 168/18723 | 1.37e-22 | 2.63e-20 | 138 |
GO:00008194 | Esophagus | ESCC | sister chromatid segregation | 157/8552 | 202/18723 | 8.41e-21 | 1.33e-18 | 157 |
GO:000705911 | Esophagus | ESCC | chromosome segregation | 238/8552 | 346/18723 | 1.72e-18 | 1.82e-16 | 238 |
GO:190285015 | Esophagus | ESCC | microtubule cytoskeleton organization involved in mitosis | 116/8552 | 147/18723 | 1.25e-16 | 9.91e-15 | 116 |
GO:000705214 | Esophagus | ESCC | mitotic spindle organization | 97/8552 | 120/18723 | 2.17e-15 | 1.33e-13 | 97 |
GO:000705114 | Esophagus | ESCC | spindle organization | 134/8552 | 184/18723 | 5.70e-14 | 2.87e-12 | 134 |
GO:005131011 | Esophagus | ESCC | metaphase plate congression | 58/8552 | 65/18723 | 1.81e-13 | 8.63e-12 | 58 |
GO:000708011 | Esophagus | ESCC | mitotic metaphase plate congression | 47/8552 | 50/18723 | 3.15e-13 | 1.47e-11 | 47 |
GO:00482853 | Esophagus | ESCC | organelle fission | 301/8552 | 488/18723 | 4.64e-13 | 2.12e-11 | 301 |
GO:00988133 | Esophagus | ESCC | nuclear chromosome segregation | 187/8552 | 281/18723 | 1.00e-12 | 4.36e-11 | 187 |
GO:005130311 | Esophagus | ESCC | establishment of chromosome localization | 67/8552 | 80/18723 | 1.92e-12 | 8.09e-11 | 67 |
GO:005000011 | Esophagus | ESCC | chromosome localization | 68/8552 | 82/18723 | 3.37e-12 | 1.32e-10 | 68 |
GO:00002802 | Esophagus | ESCC | nuclear division | 270/8552 | 439/18723 | 1.17e-11 | 4.24e-10 | 270 |
GO:00512256 | Esophagus | ESCC | spindle assembly | 85/8552 | 117/18723 | 2.72e-09 | 5.98e-08 | 85 |
GO:009030715 | Esophagus | ESCC | mitotic spindle assembly | 52/8552 | 65/18723 | 1.41e-08 | 2.77e-07 | 52 |
GO:00705078 | Esophagus | ESCC | regulation of microtubule cytoskeleton organization | 99/8552 | 148/18723 | 1.43e-07 | 2.29e-06 | 99 |
GO:190211514 | Esophagus | ESCC | regulation of organelle assembly | 116/8552 | 186/18723 | 3.15e-06 | 3.53e-05 | 116 |
GO:009022413 | Esophagus | ESCC | regulation of spindle organization | 32/8552 | 39/18723 | 3.27e-06 | 3.65e-05 | 32 |
Page: 1 2 3 4 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
EML3 | SNV | Missense_Mutation | c.562G>A | p.Glu188Lys | p.E188K | Q32P44 | protein_coding | tolerated(0.2) | benign(0.019) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
EML3 | SNV | Missense_Mutation | novel | c.2289N>T | p.Lys763Asn | p.K763N | Q32P44 | protein_coding | tolerated(0.08) | benign(0.185) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
EML3 | SNV | Missense_Mutation | rs530217979 | c.2086N>C | p.Ala696Pro | p.A696P | Q32P44 | protein_coding | deleterious(0.02) | probably_damaging(1) | TCGA-D8-A1XQ-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
EML3 | insertion | In_Frame_Ins | novel | c.307_308insTTTGGGCTGTAGCCCCAGGAGCTATTT | p.Ser103delinsIleTrpAlaValAlaProGlyAlaIleCys | p.S103delinsIWAVAPGAIC | Q32P44 | protein_coding | TCGA-A2-A0CP-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | SD | ||
EML3 | insertion | Nonsense_Mutation | novel | c.1768_1769insGATCTACATCTATAGTGTTTCCAGTGATGGTGCCA | p.Ser590Ter | p.S590* | Q32P44 | protein_coding | TCGA-A8-A07U-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Chemotherapy | 5-fluorouracil | SD | ||
EML3 | insertion | Frame_Shift_Ins | novel | c.705_706insACTGGAGACTCAGAGGGGAACATTCTCA | p.Leu236ThrfsTer11 | p.L236Tfs*11 | Q32P44 | protein_coding | TCGA-AN-A0FF-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
EML3 | insertion | Frame_Shift_Ins | novel | c.1288_1289insTGGGTTCGAGCAATTCTCCTGCCTCAGCCTCCCGGAG | p.His430LeufsTer97 | p.H430Lfs*97 | Q32P44 | protein_coding | TCGA-B6-A0RE-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
EML3 | insertion | Nonsense_Mutation | novel | c.969_970insAGAAGGGTAGTTCTGGGTTCATGAGGTGGGAGGTGCTAGTCTTATT | p.Gln324ArgfsTer8 | p.Q324Rfs*8 | Q32P44 | protein_coding | TCGA-C8-A12K-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
EML3 | SNV | Missense_Mutation | novel | c.2453N>A | p.Arg818His | p.R818H | Q32P44 | protein_coding | tolerated_low_confidence(0.64) | benign(0) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
EML3 | SNV | Missense_Mutation | c.1607N>A | p.Arg536His | p.R536H | Q32P44 | protein_coding | deleterious(0.02) | possibly_damaging(0.637) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
Page: 1 2 3 4 5 6 7 8 9 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |